Pancreatic Cancer Clinical Trials in Nanjing, Jiangsu
15 recruitingNanjing, Jiangsu, China
Showing 1–15 of 15 trials
Recruiting
Phase 2
A Phase II Study Evaluating JAB-21822 Monotherapy in Adult Patients With Pancreatic Cancer and Other Solid Tumors Harboring the KRAS p.G12C Mutation.
Pancreatic CancerSolid TumorKRAS P.G12C
Allist Pharmaceuticals, Inc.88 enrolled31 locationsNCT06008288
Recruiting
Phase 1Phase 2
Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C
Advanced Pancreatic Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.72 enrolled16 locationsNCT06821503
Recruiting
Phase 3
Polymeric Micellar Paclitaxel for Metastatic Pancreatic Cancer
Pancreatic Cancer Metastatic
Shanghai Yizhong Pharmaceutical Co., Ltd.416 enrolled2 locationsNCT06752811
Recruiting
Phase 2
Nal-IRI/5-FU/LV Chemotherapy Combined With PD-L1 Inhibitor and Multi-target Anti-angiogenic Small Molecule±SBRT as Second-line Therapy in Metastatic Pancreatic Cancer Patients
Advanced Metastatic Pancreatic Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School56 enrolled1 locationNCT06662006
Recruiting
Phase 2Phase 3
A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer
Metastatic Pancreatic Cancer
Hutchmed502 enrolled2 locationsNCT06361888
Recruiting
Phase 2
Adebrelimab and Chidamide for Pancreatic Cancer
Pancreatic Cancer, Adult
Liu Xiufeng45 enrolled1 locationNCT06584227
Recruiting
CtDNA-guided Maintenance Therapy in Pancreatic Cancer
Pancreatic Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School70 enrolled1 locationNCT07054879
Recruiting
18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis
Lung CancersPancreatic CancerThyroid Cancer+1 more
Nanjing First Hospital, Nanjing Medical University20 enrolled1 locationNCT06937112
Recruiting
99mTc Labeled FAP Targeted Molecular Probe in Early Diagnosis of Tumors
Pancreatic CancerLung CancerHead and Neck Tumor
Nanjing First Hospital, Nanjing Medical University20 enrolled1 locationNCT06438705
Recruiting
Phase 2
Nimotuzumab Combined With mFOLFIRINOX/GX as Postoperative Adjuvant Therapy in Pancreatic Cancer
Pancreatic Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School57 enrolled1 locationNCT06389760
Recruiting
Not Applicable
NALIRIFOX Combined With PD-1 Sequential Radiotherapy Versus AG Combined With PD-1 Sequential Radiotherapy as First-line Treatment of Locally Advanced Pancreatic Cancer
Locally Advanced Pancreatic Cancer
Du Juan40 enrolled2 locationsNCT06494514
Recruiting
Not Applicable
Irinotecan Liposome Combined With Oxaliplatin and Tegafur as Adjuvant Therapy for Pancreatic Cancer
Pancreatic CancerAdjuvant Therapy
Kuirong Jiang53 enrolled1 locationNCT06361316
Recruiting
Phase 2Phase 3
A Study of GB201 in Combination With Weekly Paclitaxel and Low-dose Gemcitabine in Patients With Pancreatic Cancer
Metastatic Pancreatic Cancer
1Globe Health Institute LLC336 enrolled38 locationsNCT03721744
Recruiting
Early Phase 1
Study of Neoantigen mRNA Vaccines in Patients With Resectable Pancreatic Cancer
Pancreatic Cancer
Jinling Hospital, China12 enrolled1 locationNCT06326736
Recruiting
Phase 2
A Study of Trilaciclib Combined With mFOLFIRINOX in the Treatment of Patients With Advanced Pancreatic Cancer
Pancreatic Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School30 enrolled1 locationNCT06151262